Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 6
2005 5
2006 6
2007 9
2008 18
2009 20
2010 13
2011 24
2012 29
2013 31
2014 40
2015 43
2016 31
2017 30
2018 38
2019 45
2020 42
2021 60
2022 37
2023 35
2024 29
2025 41
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

557 results

Results by year

Filters applied: . Clear all
Page 1
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.
Polcik L, Pethe A, Ashok D, Tissino E, Fernández-Rego A, Pozzo F, Danner DJ, Holst M, Martines C, Hofmann K, Dimovski AJ, Kissel S, Härzschel A, Li L, Bittolo T, Andrieux G, Haslauer T, Höpner JP, Zaborsky N, Greil R, Miething C, Duque-Afonso J, Köhler N, Boerries M, Bomben R, Duyster J, Grosse R, Gaidano G, Zamò A, Zucchetto A, Carrasco YR, Efremov DG, Gattei V, Hartmann TN. Polcik L, et al. Among authors: greil r. Blood. 2026 Mar 5:blood.2024027753. doi: 10.1182/blood.2024027753. Online ahead of print. Blood. 2026. PMID: 41790574
Successful Encorafenib and Cetuximab Re-Challenge Combined With Nivolumab in BRAF V600E Mutated, Mismatch-Repair-Proficient Metastatic Colorectal Cancer - A Case Report From the AGMT mCRC Registry.
Theodorou I, Heregger R, Greil R, Weiss L, Huemer F. Theodorou I, et al. Among authors: greil r. Clin Colorectal Cancer. 2026 Jan 21:S1533-0028(26)00004-6. doi: 10.1016/j.clcc.2026.01.004. Online ahead of print. Clin Colorectal Cancer. 2026. PMID: 41690877 No abstract available.
Real-world effectiveness and safety of belantamab mafodotin monotherapy in patients with relapsed/refractory multiple myeloma treated in Europe.
Cavo M, Schjesvold F, Dimopoulos M, Delforge M, Escalante F, Kleinman D, Lee HC, Vij R, Greil R, Melchardt T, Antonioli E, Lysen A, Camadoo-O'Byrne L, Bitetti J, D'Estrube T, Fry M, Byrne J, Vossen CY, Sapra S, Benson VS, Mouro J, Hultcrantz M. Cavo M, et al. Among authors: greil r. Haematologica. 2026 Jan 22. doi: 10.3324/haematol.2025.289034. Online ahead of print. Haematologica. 2026. PMID: 41568469 Free article.
Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer.
Marteau V, Nemati N, Handler K, Raju D, Kirchmair A, Rieder D, Kvalem Soto E, Fotakis G, De Lange G, Carollo S, Boeck N, Rossi A, Daum S, Scheiber A, Amann A, Seeber A, Gasser E, Ormanns S, Günther M, Martowicz A, Loncova Z, Lamberti G, Krogsdam A, Carlet M, Horvath L, Eling MT, Fazilaty H, Valenta T, Sturm G, Sopper S, Pircher A, Stoitzner P, Wild PJ, Welker P, May PJ, Ziegler P, Tschurtschenthaler M, Neureiter D, Huemer F, Greil R, Weiss L, Ijsselsteijn M, de Miranda NFCC, Wolf D, Arnold IC, Salcher S, Trajanoski Z. Marteau V, et al. Among authors: greil r. Cancer Cell. 2026 Jan 12;44(1):146-165.e14. doi: 10.1016/j.ccell.2025.12.003. Cancer Cell. 2026. PMID: 41529665 Free article.
Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria - a Large Single-Center Experience.
Leisch M, Kiem D, Grabmer C, Kugler A, Pocobelli G, Marie-Christina M, Schöpf B, Egle A, Greil R, Melchardt T. Leisch M, et al. Among authors: greil r. Technol Cancer Res Treat. 2026 Jan-Dec;25:15330338251410356. doi: 10.1177/15330338251410356. Epub 2026 Jan 8. Technol Cancer Res Treat. 2026. PMID: 41505298 Free PMC article.
Loading of STING Agonist into Lipid Nanoparticles Boosts Dendritic Cell Activation.
Ribeiro AR, Eguskiza A, Dang HH, Neuper T, Unger MS, Rodriguez Comas L, Steiner M, Sieberer H, Zaborsky N, Greil R, Vilar I Hernandez M, Jonkheijm P, Fiammengo R, Horejs-Hoeck J. Ribeiro AR, et al. Among authors: greil r. ACS Omega. 2025 Nov 21;10(48):58465-58479. doi: 10.1021/acsomega.5c06105. eCollection 2025 Dec 9. ACS Omega. 2025. PMID: 41502679 Free PMC article.
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial.
Massonnaud CR, Peiffer-Smadja N, Poignard P, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lapique EL, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Le Moing V, Piroth L, Sellier P, Lescure X, Trøseid M, Clevenbergh P, Dalgard O, Gallien S, Gousseff M, Loubet P, Vardon-Bounes F, Visée C, Belkhir L, Botelho-Nevers É, Cabié A, Kotanidou A, Lanternier F, Rouveix-Nordon E, Silva S, Thiery G, Carcelain G, Diallo A, Mercier N, Terzić V, Bouscambert-Duchamp M, Gaymard A, Destras G, Josset L, Belhadi D, Billard N, Guedj J, Han TH, Couffin-Cadiergues S, Dechanet A, Delmas C, Esperou H, Fougerou-Leurent C, Le Mestre S, Métois A, Noret M, Bally I, Dergan-Dylon S, Tubiana S, Kalif O, Bergaud N, Leveau B, Eustace J, Greil R, Hajdu E, Halanova M, Paiva JA, Piekarska A, Baño JR, Tonby K, Trojánek M, Tsiodras S, Unal S, Burdet C, Costagliola D, Yazdanpanah Y, Mentré F, Ader F, Hites M; DisCoVeRy study group. Massonnaud CR, et al. Among authors: greil r. Clin Microbiol Infect. 2025 Dec 20:S1198-743X(25)00623-8. doi: 10.1016/j.cmi.2025.12.014. Online ahead of print. Clin Microbiol Infect. 2025. PMID: 41429349
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.
Falchi L, Nijland M, Huang H, Linton KM, Seymour JF, Tao R, Kwiatek M, Costa A, Vassilakopoulos TP, Greil R, Jiménez-Ubieto A, Gangatharan SA, Benjamini O, Thieblemont C, Tucci A, Elinder-Camburn A, Illes A, Novak J, Pavlovsky MA, McDonald A, Yoon DH, Maruyama D, Sunkersett G, Mei JP, Mukherjee N, Zhu F, Alshreef A, Favaro E, Morschhauser F; EPCORE FL-1 Investigators. Falchi L, et al. Among authors: greil r. Lancet. 2026 Jan 10;407(10524):161-173. doi: 10.1016/S0140-6736(25)02360-8. Epub 2025 Dec 7. Lancet. 2026. PMID: 41371238 Free article. Clinical Trial.
557 results